Harm Reduction Learning Institute
DC Health

The COVID-19 Pandemic: Practice and Policy Considerations For Patients with Opioid Use Disorder

This article details US policy updates that are loosening restrictions around MOUD prescribing in light of COVID-19.


FDA issues warning for products marketed to treat opioid withdrawal

The FDA sent a warning letter to EPH Technologies, accusing it of marketing and selling unapproved drugs.


Getting Off Right: A Safety Manual for Injection Drug Users

A comprehensive manual on safer injection practices


The American Opioid Epidemic in Special Populations: Five Examples

This manuscript identifies segments of the population that are disproportionately affected by the opioid epidemic.


Opioid death rates soared in communities where pain pills flowed

Death rates from opioids soared in the towns, cities and counties that were saturated with billions of prescription pain pills from 2006 through 2012, according to government death data and a previously undisclosed database of opioid shipments.


Opioid Clinic Use Doubles After COVID Arrives at Alabama HIV Center

At a large HIV clinic in Birmingham, Alabama, overall appointments for outpatient opioid use disorder (OUD) doubled after the COVID-19 epidemic arrived in March 2020.